Abiopharma

Events and transactions

Net Asset Value(s)

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

CARES Phase III clinical programme did not meet primary endpoint in overall light chain amyloidosis population

Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25

Rail Vision and Railserve, a Marmon Rail Company, Sign MOU to Expand Collaboration

Pfizer Inc. - Seven-Year Analysis from Pfizer’sLORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Bristol Myers Squibb - Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma

Encompass Health Corporation - Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia

SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting